Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism IP6K1 inhibitors(inositol hexakisphosphate kinase 1 inhibitors), IP6K2 inhibitors(inositol hexakisphosphate kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H13NO3 |
InChIKeyFGCSKRKOSIKUGT-UHFFFAOYSA-N |
CAS Registry2922283-43-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | US | 12 May 2022 |